Table of Contents
What Is Corbis 2.5?
Corbis 2.5 is a prescription medication belonging to the class of drugs known as beta-blockers, specifically containing the active ingredient Bisoprolol Fumarate (2.5 mg) . It is primarily used to manage cardiovascular conditions, most notably hypertension (high blood pressure) and chronic stable angina (chest pain) . The medication works by selectively blocking beta-1 adrenergic receptors in the heart, which results in a slower heart rate and reduced force of contraction, ultimately lowering blood pressure and decreasing the heart’s demand for oxygen .
Corbis is manufactured by Torrent Pharmaceuticals Limited in India and by Roemmers in Argentina, with the 2.5 mg strength being the lowest available dosage, typically used for initiating therapy or for patients requiring gentle blood pressure control . The medication is available in multiple strengths including 2.5 mg, 5 mg, and 10 mg tablets, allowing physicians to titrate the dose according to individual patient needs . It is important to note that Corbis 2.5 is a prescription-only drug and should never be self-medicated or purchased without a doctor’s recommendation .
Overview
| Aspect | Details |
| Generic Name | Bisoprolol Fumarate |
| Strength | 2.5 mg |
| Drug Class | Beta-1 Selective Adrenergic Blocker (Cardioselective Beta-Blocker) |
| Manufacturer (India) | Torrent Pharmaceuticals Ltd. |
| Manufacturer (Argentina) | Roemmers S.A.I.C.F. |
| Prescription Required | Yes (Schedule H Drug in India) |
| Therapeutic Category | Antihypertensive, Antianginal, Antiarrhythmic |
| Mechanism | Beta-1 receptor blockade (reduces heart rate, contractility, and renin release) |
| Bioavailability | Approximately 90% |
| Half-Life | 10-12 hours |
| Protein Binding | Approximately 30% |
| Metabolism | Hepatic (CYP3A4) |
| Excretion | Renal (50% unchanged, 50% metabolites) |
| Onset of Action | 1-2 hours |
| Duration of Action | 24 hours |
| FDA Pregnancy Category | C (Risk cannot be ruled out) |
Composition and Key Ingredients of Corbis 2.5
Corbis 2.5 tablets contain a single active pharmaceutical ingredient along with several inactive excipients that help in tablet formation, stability, and absorption . The complete composition is as follows:
| Component | Type | Quantity | Function |
| Bisoprolol Fumarate | Active Ingredient | 2.5 mg | Beta-blocker; lowers blood pressure and heart rate |
| Pregelatinized Corn Starch | Excipient | 15-17.5 mg | Binder and disintegrant |
| Insoluble Povidone | Excipient | 5-7 mg | Binder for tablet integrity |
| Colloidal Silicic Acid | Excipient | 0.875 mg | Glidant; improves powder flow |
| Microcrystalline Cellulose | Excipient | 100-136.75 mg | Filler and disintegrant |
| Magnesium Stearate | Excipient | 0.875 mg | Lubricant; prevents sticking |
| Hydroxypropyl Methylcellulose | Coating Agent | 3-4.35 mg | Film coating for tablet |
| Titanium Dioxide | Coating Agent | 1.355-1.93 mg | Opacifier and whitening agent |
| Triacetin | Coating Agent | 0.62 mg | Plasticizer for film coating |
| Iron Oxide Red/Yellow | Coloring Agent | Trace amounts | Color identification |
Note: The 2.5 mg tablet is typically white or off-white in color, distinguishing it from higher strengths which may have color additives for identification purposes .
How Corbis 2.5 Works in the Body
Corbis 2.5 (Bisoprolol) is a highly cardioselective beta-1 adrenergic receptor blocker, meaning it specifically targets beta-1 receptors located primarily in the heart, with minimal effect on beta-2 receptors found in the lungs and blood vessels . This selectivity is crucial as it allows the medication to achieve its therapeutic effects while reducing the risk of bronchospasm (breathing difficulties) that non-selective beta-blockers may cause.
Mechanism of Action:
- Heart Rate Reduction: By blocking beta-1 receptors in the sinoatrial (SA) node, bisoprolol decreases the firing rate of the heart’s natural pacemaker, resulting in a slower resting heart rate (negative chronotropic effect) .
- Reduced Contractility: The medication decreases the force of myocardial contraction (negative inotropic effect), which reduces the amount of oxygen the heart muscle requires to pump blood .
- Decreased Cardiac Output: With slower rate and reduced force, the overall cardiac output decreases, leading to lower blood pressure .
- Renin Suppression: Bisoprolol inhibits the release of renin from the kidneys, which reduces the formation of angiotensin II (a potent vasoconstrictor), further contributing to blood pressure reduction .
- Oxygen Demand Reduction: For angina patients, the combination of slower heart rate and reduced contractility means the heart requires less oxygen during both rest and exercise, preventing or delaying the onset of chest pain .
Medical Uses of Corbis 2.5 in India
In India, Corbis 2.5 is prescribed for several cardiovascular indications. The medication is recognized by the Indian medical community as a first-line or adjunctive therapy for the following conditions :
| Medical Condition | Description | Role of Corbis 2.5 |
| Essential Hypertension | Chronic elevation of blood pressure (≥140/90 mmHg) without identifiable cause | First-line monotherapy or combination therapy to reduce cardiovascular risk |
| Chronic Stable Angina | Chest pain occurring predictably with exertion or emotional stress | Reduces frequency and severity of angina attacks by decreasing myocardial oxygen demand |
| Chronic Heart Failure | Stable NYHA Class II-III heart failure with reduced ejection fraction | Adjunctive therapy with ACE inhibitors, diuretics, and digoxin to reduce mortality and hospitalizations |
| Post-Myocardial Infarction | Following heart attack (secondary prevention) | Reduces risk of reinfarction and sudden cardiac death |
| Tachyarrhythmias | Supraventricular tachycardia, atrial fibrillation with rapid ventricular response | Controls ventricular rate |
| Prevention of Migraine | Off-label use in some cases | Reduces frequency of migraine attacks |
Important Distinction: In India, combination products containing bisoprolol are also available, including:
- Corbis T 2.5: Contains Bisoprolol + Telmisartan (ARB) for enhanced blood pressure control
- Corbis AM 2.5: Contains Bisoprolol + Amlodipine (Calcium Channel Blocker)
- Corbis D 2.5: Contains Bisoprolol + Dapagliflozin (SGLT2 inhibitor) for diabetic patients with heart failure
Benefits of Using Corbis 2.5 Tablets
The use of Corbis 2.5 offers multiple clinical benefits for patients with cardiovascular conditions. Below is a comprehensive list of advantages:
| Benefit | Explanation | Evidence Level |
| Effective Blood Pressure Reduction | Lowers both systolic and diastolic blood pressure by 10-20 mmHg on average, achieving target BP in 50-70% of patients | High |
| 24-Hour Coverage | Long half-life allows once-daily dosing, improving medication adherence and providing consistent blood pressure control throughout the day | High |
| Cardioprotective Effects | Reduces the risk of heart attack, stroke, and sudden cardiac death in patients with hypertension or heart failure | High |
| Angina Prevention | Decreases the frequency and severity of chest pain episodes, improving exercise tolerance and quality of life | High |
| Improved Survival in Heart Failure | In stable chronic heart failure, bisoprolol reduces all-cause mortality by approximately 34% compared to placebo | High |
| Reduced Hospitalizations | Lowers the rate of hospital admissions for cardiovascular events, particularly heart failure decompensation | High |
| Beta-1 Selectivity | Minimal effects on beta-2 receptors means lower risk of bronchospasm compared to non-selective beta-blockers like propranolol | Moderate |
| No Intrinsic Sympathomimetic Activity | Does not partially activate receptors, providing consistent heart rate reduction without unexpected stimulation | High |
| Metabolic Neutrality | Unlike older beta-blockers, bisoprolol has minimal adverse effects on lipid profiles and blood sugar control | Moderate |
| Well-Established Safety Profile | Decades of clinical use with extensive safety data; one of the most studied beta-blockers worldwide | High |
Recommended Dosage and Usage Guidelines
The dosage of Corbis 2.5 must be individualized based on the patient’s condition, response to treatment, and tolerance. All dosages mentioned below are general guidelines and should be strictly followed as prescribed by a physician .
| Condition | Starting Dose | Maintenance Dose | Maximum Dose | Titration Schedule |
| Hypertension | 2.5-5 mg once daily | 5-10 mg once daily | 20 mg/day | Increase at 2-week intervals if needed |
| Angina Pectoris | 2.5-5 mg once daily | 5-10 mg once daily | 20 mg/day | Increase gradually over 1-2 weeks |
| Chronic Heart Failure (Stable NYHA II-III) | 1.25 mg once daily | 2.5-10 mg once daily | 10 mg/day | Double dose every 2 weeks as tolerated |
| Elderly Patients | 2.5 mg once daily | 5 mg once daily | 10 mg/day | Slower titration; monitor closely |
| Severe Renal Impairment (CrCl <20 mL/min) | 2.5 mg once daily | 2.5-5 mg once daily | 10 mg/day | Caution; monitor for bradycardia |
| Severe Hepatic Impairment | 2.5 mg once daily | 2.5-5 mg once daily | 10 mg/day | Use with extreme caution |
Administration Instructions:
- Take the tablet once daily in the morning with or without food
- Swallow the tablet whole with a glass of water; do not crush, chew, or break it
- For patients who have difficulty swallowing, tablets may be split along the score line if prescribed
- Take at the same time each day to maintain consistent blood levels
- If a dose is missed, take it as soon as remembered unless it is within 8 hours of the next dose; in that case, skip the missed dose
- Never double the dose to make up for a missed one
Duration of Treatment:
Corbis 2.5 is typically a long-term medication for chronic conditions like hypertension and heart failure. Do not stop taking the medication abruptly, as sudden withdrawal can cause rebound hypertension, worsening angina, or heart attack .
Possible Side Effects of Corbis 2.5
Like all medications, Corbis 2.5 can cause side effects, although not everyone experiences them. Side effects are generally dose-dependent and often improve as the body adjusts to the medication .
| System | Common (≥1%) | Uncommon (0.1-1%) | Rare (<0.1%) |
| Cardiovascular | Bradycardia (slow heart rate), Cold extremities, Hypotension | Worsening of heart failure, Conduction disturbances (AV block) | Palpitations, Chest pain |
| Nervous System | Fatigue (10%), Dizziness, Headache | Sleep disturbances, Nightmares, Depression | Hallucinations, Confusion, Memory impairment |
| Respiratory | Shortness of breath (in susceptible individuals) | Bronchospasm (in asthmatics), Rhinitis | Pneumonia |
| Gastrointestinal | Nausea, Vomiting, Diarrhea, Constipation | Dry mouth | Hepatitis, Elevated liver enzymes |
| Musculoskeletal | Muscle weakness, Joint pain | Muscle cramps | — |
| Dermatological | — | Rash, Itching, Flushing | Hair loss, Psoriasis exacerbation |
| Metabolic | — | Increased triglycerides, Decreased HDL | Hypoglycemia masking (in diabetics) |
| Reproductive | — | Reduced libido, Erectile dysfunction | — |
| Ophthalmologic | — | Dry eyes, Visual disturbances | — |
Management Tips:
- Fatigue/Dizziness: Often temporary; avoid driving or operating machinery initially. Take the medication at bedtime if fatigue is bothersome.
- Cold Extremities: Wear warm gloves and socks; avoid smoking which worsens circulation.
- Bradycardia: Report resting heart rate below 55 bpm to your doctor; dose adjustment may be needed.
- Gastrointestinal issues: Take with food to reduce nausea.
Precautions and Safety Warnings Before Use
Before starting Corbis 2.5, patients must be aware of several important safety considerations. The following warnings are based on clinical guidelines and product labeling :
- Alcohol: Avoid or limit alcohol consumption as it can enhance the blood pressure-lowering effect and increase dizziness
- Driving: Do not drive or operate heavy machinery until you know how the medication affects you, as dizziness and fatigue are common initially
- Dehydration: Avoid situations that cause fluid loss (excessive sweating, diarrhea, vomiting) as this can exacerbate hypotension
- Pregnancy: Use only if clearly needed and prescribed by a doctor. May cause fetal bradycardia and low birth weight if used in late pregnancy
- Breastfeeding: Bisoprolol passes into breast milk; consult your doctor before breastfeeding while taking this medication
Corbis 2.5 for Blood Pressure and Heart Health
Corbis 2.5 plays a significant role in the long-term management of hypertension and overall cardiovascular health. Understanding how it contributes to heart health can help patients appreciate the importance of adherence to therapy .
Impact on Blood Pressure:
- Mechanism: Reduces cardiac output and suppresses renin release, leading to decreased peripheral vascular resistance over time
- Expected Reduction: Typically lowers systolic BP by 10-20 mmHg and diastolic BP by 5-10 mmHg in hypertensive patients
- Time to Full Effect: Maximum blood pressure reduction is usually achieved within 1-2 weeks of starting therapy or dose adjustment
- Sustained Control: Once-daily dosing provides 24-hour blood pressure coverage, including the early morning surge when cardiovascular risk is highest
Impact on Heart Health:
- Left Ventricular Function: In heart failure patients, bisoprolol has been shown to improve left ventricular ejection fraction (LVEF) by 5-10% over 6-12 months
- Heart Rate Control: Reduces resting heart rate by 10-15 beats per minute, which correlates with improved cardiovascular outcomes
- Myocardial Oxygen Demand: Decreases the heart’s workload, particularly beneficial for patients with coronary artery disease
- Arrhythmia Suppression: Reduces the incidence of ventricular and supraventricular arrhythmias, including atrial fibrillation
- Mortality Benefit: In landmark clinical trials (CIBIS-II), bisoprolol reduced all-cause mortality by 34% and sudden death by 44% in patients with chronic heart failure
Availability and Prescription Requirements in India
Corbis 2.5 is widely available across India but is strictly regulated as a prescription-only medication . Below are the key details regarding its availability:
| Aspect | Details |
| Regulatory Status | Schedule H drug under the Drugs and Cosmetics Act, 1940 |
| Prescription Requirement | Mandatory; cannot be purchased without a valid prescription from a registered medical practitioner |
| Prescription Validity | Generally 30 days from date of issue (varies by state) |
| Generic Availability | Yes, multiple generic versions of bisoprolol 2.5 mg are available at lower cost |
| Brand Availability | Corbis (Torrent), Bisotens (Lupin), Bisoheart (Mankind), Biselect (Intas), and many others |
| Storage Requirements | Store below 30°C in a dry place away from direct sunlight |
| Shelf Life | Typically 24-36 months from manufacturing date |
| Return Policy | Cannot be returned once sold due to regulatory and safety reasons |
Prescription Requirements:
A valid prescription for Corbis 2.5 must include:
- Patient’s full name and age
- Date of prescription
- Name and signature of the prescribing doctor (with registration number)
- Name of medication (Corbis 2.5 or Bisoprolol 2.5 mg)
- Dosage instructions (e.g., “One tablet once daily”)
- Duration of treatment
- Refill instructions (if any)
Where to Buy Corbis 2.5 in India (Online & Offline)
Corbis 2.5 can be purchased from various authorized sources across India. However, all purchases require a valid prescription from a registered medical practitioner .
Offline Purchase Options
| Channel | Description | Advantages | Disadvantages |
| Local Retail Pharmacies | Medical stores in your neighborhood (e.g., Apollo Pharmacy, MedPlus, Guardian, local chemists) | Immediate availability; pharmacist consultation; cash payment options | May not always have stock; price variations between stores |
| Hospital Pharmacies | Pharmacies located within government or private hospitals | Usually well-stocked; authentic products; competitive pricing | Requires hospital visit; limited to hospital working hours |
| Chain Pharmacy Outlets | National chains like Apollo Pharmacy, MedPlus, Wellness Forever, Netmeds offline stores | Standardized pricing; genuine products; multiple locations | Limited to metropolitan and tier-1 cities |
Online Purchase Options
| Platform | Type | Prescription Upload Required | Delivery Time | Notes |
| Tata 1mg | E-pharmacy | Yes (upload during checkout) | 2-5 days | Offers discounts; authentic products |
| Netmeds | E-pharmacy | Yes | 2-5 days | Wide availability; frequent coupon codes |
| PharmEasy | E-pharmacy | Yes | 2-5 days | Subscription options available |
| Medkart | Generic pharmacy (online) | Yes | 3-6 days | Lower cost generic alternatives available |
| Apollo Pharmacy Online | E-pharmacy (chain) | Yes | 2-4 days | Trusted brand; integrated with offline stores |
| Practo | Telemedicine + Pharmacy | Yes (e-prescription accepted) | 2-5 days | Can consult doctor online and order medicine |
Important Notes for Online Purchase:
- Always use licensed e-pharmacies registered with the Central Drugs Standard Control Organization (CDSCO)
- Upload a clear photo of your valid prescription
- A pharmacist will verify the prescription before dispensing
- Do not purchase from unauthorized websites or social media sellers
- Check the expiry date upon delivery
- Verify the product packaging and seal before accepting
Final Verdict: Is Corbis 2.5 Safe and Effective?
Corbis 2.5 (Bisoprolol) is a safe and well-established medication when used as prescribed and under medical supervision. With over three decades of clinical use worldwide and extensive safety data from large clinical trials, it has earned its place as a first-line therapy for hypertension, angina, and chronic heart failure .
The safety profile is favorable, with most side effects being mild to moderate and dose-dependent. The most common issues—fatigue, dizziness, and bradycardia—typically resolve or become tolerable within the first few weeks of therapy. The cardioselective nature of bisoprolol makes it safer for patients with respiratory conditions compared to non-selective beta-blockers, though caution is still required in asthmatics .
However, the single most important safety consideration is that Corbis 2.5 should never be stopped abruptly. Sudden withdrawal can lead to rebound hypertension, worsening angina, myocardial infarction, or even sudden death in high-risk patients . Any discontinuation must be done under medical supervision with gradual dose tapering over 1-2 weeks.